Spring 2026 funding cycle: Applications available until Monday, March 2nd, 2pm PT.
- Call opens: Wednesday, January 28, 2026
- Deadline: Monday, March 2, 2026 (2:00 pm PST)
- Funding results: Available before end of June 2026
Amount available: $50,000 in direct costs for 1 year
Apply through the UCSF Resource Allocation Program (RAP) portal
The CFAR Mentored Scientist Award (our primary award program) is a mentoring and training grant targeted toward early stage (either at a senior stage of clinical or postdoctoral training or junior faculty) investigators at UCSF or affiliated partner institutes in the conduct of an HIV research project. These awards are designed to acquire preliminary data and research skills to prepare investigators for a future grant effort. Applicants for this award must indicate a faculty research mentor(s) who will commit to guiding the applicant throughout the duration of the proposed project.
Designation of Mentor
All Mentored award applications from individuals at the Assistant Professor level or below require an HIV research mentor. Mentors can, but are not required to, have supervisory authority over the applicant. CFAR requires your research mentor’s support to advise and guide the research portion of your application before submitting it to RAP.
Of high interest to CFAR are investigations ranging from basic pathogenesis to clinical outcomes in the research areas of HIV/aging and inflammation, latency, cure, vaccines, co-infections, HIV in women, implementation science, and research related to HIV-infected and HIV-impacted Bay Area populations. Projects must be within NIH’s HIV/AIDS research high or medium priority areas. Projects in closely related areas (e.g. TB, HCV, drug use, etc.) must be clearly linked to HIV in order to be eligible for CFAR funding.
The award amount is $50,000 in direct costs for one year.
CFAR requests that applicants review the NIAID HIV Language Guide as they prepare their proposals so that they can follow best practices on language for communicating respectfully about HIV and related topics, including the use of person-first, non-stigmatizing language. Please contact us if you have any questions about this request.
For more detailed information about this RFA, please see the RAP Portal.
To see examples of previously funded projects, see the list below.
Mentored Science Awardees
135 Awards
-
Understanding how trafficking of blood CD4 T cells into HIV-infected lymphoid tissues triggers sensitivity to pyroptotic cell death
Understanding how trafficking of blood CD4 T cells into HIV-infected lymphoid tissues triggers sensitivity to pyroptotic cell death
Abstract
The recent recognition that a host innate antiviral immune response mediates up to 95% of CD4 T-cell (CD4) death during HIV infection has markedly changed our understanding of HIV pathogenesis. Abortively infected resting CD4 are swept up into a fiery, highly inflammatory programmed cell death termed pyroptosis. In sharp contrast to resting lymphoid tissue CD4, circulating blood CD4 are highly resistant to pyroptosis.
-
Understanding how trafficking of blood CD4 T cells into HIV-infected lymphoid tissues triggers sensitivity to pyroptotic cell death
Understanding how trafficking of blood CD4 T cells into HIV-infected lymphoid tissues triggers sensitivity to pyroptotic cell death
Abstract
The recent recognition that a host innate antiviral immune response mediates up to 95% of CD4 T-cell (CD4) death during HIV infection has markedly changed our understanding of HIV pathogenesis. Abortively infected resting CD4 are swept up into a fiery, highly inflammatory programmed cell death termed pyroptosis. In sharp contrast to resting lymphoid tissue CD4, circulating blood CD4 are highly resistant to pyroptosis.
-
Cellular targets of early viral replication in RhCMV/SIV-vaccinated macaques with Mamu-E-restricted T cell responses
Cellular targets of early viral replication in RhCMV/SIV-vaccinated macaques with Mamu-E-restricted T cell responses
Abstract
Rhesus CMV-vectored SIV (RhCMV/SIV) vaccines have been shown to provide protection against infection in ~50% of adult macaques. Circulating CTL frequency in individual animals was shown to be correlated with protection in only some groups and at selected pre-infection time points, suggesting the possibility that gut-resident CTL are more important. We will test if gut-resident, Mamu-E-restricted, SIV-specific T cell responses elicited by the RhCMV/SIV vaccine will alter the composition of the earliest expanding virus population, due to restriction of viral replication in T cells.
-
Cellular targets of early viral replication in RhCMV/SIV-vaccinated macaques with Mamu-E-restricted T cell responses
Cellular targets of early viral replication in RhCMV/SIV-vaccinated macaques with Mamu-E-restricted T cell responses
Abstract
Rhesus CMV-vectored SIV (RhCMV/SIV) vaccines have been shown to provide protection against infection in ~50% of adult macaques. Circulating CTL frequency in individual animals was shown to be correlated with protection in only some groups and at selected pre-infection time points, suggesting the possibility that gut-resident CTL are more important. We will test if gut-resident, Mamu-E-restricted, SIV-specific T cell responses elicited by the RhCMV/SIV vaccine will alter the composition of the earliest expanding virus population, due to restriction of viral replication in T cells.
-
Reactivation of HIV transcription from latently infected cells by some Iranian herbal extracts
Reactivation of HIV transcription from latently infected cells by some Iranian herbal extracts
Abstract
The proposed study will test the effect of herbal extracts commonly used in Iran by various HIV and cellular based assays available at UCSF, and provide important information to develop effective and affordable anti-HIV latency therapies to those who have limited access to expensive modern medicine. Also, I will maintain the collaboration with Dr. Peterlin after completion of the proposed study during my sabbatical stay at UCSF, which will contribute to potential new discovery of cellular pathways to regulate HIV transcription and latency.
-
Reactivation of HIV transcription from latently infected cells by some Iranian herbal extracts
Reactivation of HIV transcription from latently infected cells by some Iranian herbal extracts
Abstract
The proposed study will test the effect of herbal extracts commonly used in Iran by various HIV and cellular based assays available at UCSF, and provide important information to develop effective and affordable anti-HIV latency therapies to those who have limited access to expensive modern medicine. Also, I will maintain the collaboration with Dr. Peterlin after completion of the proposed study during my sabbatical stay at UCSF, which will contribute to potential new discovery of cellular pathways to regulate HIV transcription and latency.
-
CD30/CD30L signaling pathways in HIV-1 mediated B cell dysfunction
CD30/CD30L signaling pathways in HIV-1 mediated B cell dysfunction
Abstract
HIV-1 induced B cell dysfunction typically presents as a loss of memory B cells and attenuated antibody responses, paradoxically with concomitant increases in activated B cells and hypergammaglobulinaemia. While some loss of functionality could be due to the loss T cell help, T cell triggering of inhibitory signaling pathways has also been implicated. Of these pathways, members of the TNF-receptor superfamily and subsequent downstream signaling events appear to have a prominent impact on regulating B cell function.
-
CD30/CD30L signaling pathways in HIV-1 mediated B cell dysfunction
CD30/CD30L signaling pathways in HIV-1 mediated B cell dysfunction
Abstract
HIV-1 induced B cell dysfunction typically presents as a loss of memory B cells and attenuated antibody responses, paradoxically with concomitant increases in activated B cells and hypergammaglobulinaemia. While some loss of functionality could be due to the loss T cell help, T cell triggering of inhibitory signaling pathways has also been implicated. Of these pathways, members of the TNF-receptor superfamily and subsequent downstream signaling events appear to have a prominent impact on regulating B cell function.
-
Impact of a novel multicomponent nutrition intervention on cardiovascular disease risk factors among food-insecure adults with HIV in the Dominican Republic
Impact of a novel multicomponent nutrition intervention on cardiovascular disease risk factors among food-insecure adults with HIV in the Dominican Republic
Abstract
Cardiovascular disease (CVD) is the leading cause of mortality in Latin America and the Caribbean (LAC), and has arisen as a major clinical and public health challenge in HIV. Social and economic vulnerability may potentiate increased CVD risk among PLHIV by reducing access to a healthy diet, increasing stress, and increasing maladaptive coping behaviors (e.g. alcohol consumption and smoking). In particular, research suggests food insecurity as a key structural barrier that may undermine CVD prevention efforts among PLHIV.
-
Impact of a novel multicomponent nutrition intervention on cardiovascular disease risk factors among food-insecure adults with HIV in the Dominican Republic
Impact of a novel multicomponent nutrition intervention on cardiovascular disease risk factors among food-insecure adults with HIV in the Dominican Republic
Abstract
Cardiovascular disease (CVD) is the leading cause of mortality in Latin America and the Caribbean (LAC), and has arisen as a major clinical and public health challenge in HIV. Social and economic vulnerability may potentiate increased CVD risk among PLHIV by reducing access to a healthy diet, increasing stress, and increasing maladaptive coping behaviors (e.g. alcohol consumption and smoking). In particular, research suggests food insecurity as a key structural barrier that may undermine CVD prevention efforts among PLHIV.